Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Promise of PCSK9 and Lipoprotein(a) as Targets for Gene Silencing Therapies

29 Jul 2023

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atherosclerosis and Cardiovascular Diseases
Share to Cholesterol and Lipid Metabolism
Share to Lipoproteins and Cardiovascular Health

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 37524569
DOI: 10.1016/j.clinthera.2023.07.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Promise of PCSK9 and Lipoprotein(a) as Targets for Gene Silencing TherapiesPMID 37524569Read ↗

Gene-based therapy in lipid management: the winding road from promise to practiceSemantic proximity Read ↗

PCSK9: a promising therapeutic target for dyslipidemias?Semantic proximity Read ↗

Molecular aspects of hypercholesterolemia treatment: current perspectives and hopes.Semantic proximity Read ↗

PCSK9 pathway-noncoding RNAs crosstalk: Emerging opportunities for novel therapeutic approaches in inflammatory atherosclerosisSemantic proximity Read ↗

CRISPR-Cas12a delivery by DNA-mediated bioresponsive editing for cholesterol regulationSemantic proximity Read ↗

Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9Semantic proximity Read ↗

Precision Regulation of LDL Metabolism: Epigenetic and Genetic Approaches Targeting LDLR, APOB, and PCSK9Semantic proximity Read ↗

Lipoprotein(a)Semantic proximity Read ↗

Lipoprotein(a): the revenantSemantic proximity Read ↗

In vivo adeno-associated virus-mediated LDLR/PCSK9 intervention for familial hypercholesterolemiaSemantic proximity Read ↗

PCSK9 inhibitors: the next frontier in low-density lipoprotein lowering.Semantic proximity Read ↗

New Approaches for Targeting PCSK9: Small-Interfering Ribonucleic Acid and Genome EditingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.